MHH project wins start-up funding competition organised by Lower Saxony research incubator Institute for Biomedical Translation Lower Saxony.

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

The survey was disseminated among biopharma CEOs and regulatory affairs leaders and focused on recent experiences with the ...

The open-label, multi-part Phase II trial will assess RCT2100’s biodistribution, safety, and tolerability via oral inhalation ...

A shrew's brain and other organs can shrink by as much as 30% and then grow back in the spring. Once the brain of a human ...

Flagship Pioneering, led by Moderna’s co-founder, has launched scores of new companies — but first, it tries to kill them.

Differences between men and women in intelligence and behaviour have been proposed and disputed for decades. Now, a growing ...

Mount Sinai and Israel’s largest medical center are using artificial intelligence to map the hidden corners of the human ...

Ryan deserved the freedom to lead without coercion. UVA deserved better than political intrusion. And Virginians deserve ...

ReviR Therapeutics, a biotech company focused on developing innovative treatments for neurogenetic diseases, announced today that it has been awarded a $4.6M grant from the California Institute for ...

After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the ...

Pancreatic cancer is the twelfth most common cancer worldwide. It may seem rare, but awareness is important to spot early signs of pancreas issues.